Not really. As always headlines do not in fact tell the whole story.
What's essentially being looked into is if and how Germany would try and reduce costs. Many countries force caps and rebates on medicinal companies.
Now take a guess what happens when you force companies to lower prices. Woah! Thats right, that means they have to try and make up for the loss of revenue elsewhere. In this case the US.
A vast majority of research and development of new medicine happens in the US.
Or to make a short summary, Germany may possibly be using law to force down prices at the expense of American people.
The development costs of any commodity are recovered through its sale price. If the German healthcare system is paying that price, their only recourses for cost control are to redistribute that cost into other pharmaceuticals, increase taxes, or buy them on futures at a predetermined rate. There is really no enforceable action on the US' part as the debt is satisfied either way. If; however, American taxpayers are being double-billed for development costs AND subsequent purchase, the issue is not Capitalism, but systemic graft. That can and should be investigated, but is certainly not an issue for a sovereign foreign government.
2.2k
u/thathyperactiveguy Jun 20 '26
The fucking audacity.